Meeting
2024 ASCO Annual Meeting
Algorithmic precision in immune checkpoint therapy response prediction for lung cancer: Evaluating the Digital Drug Assignment model's clinical performance.
Authors
Barbara Vodicska
Genomate Health Inc, Cambridge, MA
Barbara Vodicska , Eniko Kispeter , Csenge Somodi , Robert Doczi , Dora Lakatos , Dora Tihanyi , Anna Dirner , Reka Szalkai-Denes , Matyas Vidermann , Marton Bolyacz , Akos Takacs , Maria Kocsis-Steinbach , Anna Varjassy , Christophe Le Tourneau , Istvan Petak , Maud Kamal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 8523)
DOI
10.1200/JCO.2024.42.16_suppl.8523
Abstract #
8523
Poster Bd #
387
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Efficacy and safety of vebreltinib in patients with advanced NSCLC harboring MET exon 14-skipping: Results of 2.5-year follow-up in KUNPENG.
First Author: Jin-Ji Yang
Poster
2024 ASCO Annual Meeting
Long-term efficacy and safety of larotrectinib in patients with TRK fusion lung cancer.
First Author: Alexander E. Drilon
Poster
2024 ASCO Annual Meeting
Clinical-genomic characteristics in patients with EGFR-mutated non-small cell lung cancer harboring MET copy number gains after progression on EGFR-TKI: A report from LC-SCRUM-TRY.
First Author: Tsuyoshi Hirata
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comprehensive clinico-molecular profile and efficacy of anti-HER2 therapy for HER2-amplified biliary tract cancer.
First Author: Kanae Inoue